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Abstract
Background: Mammalian sperm-oocyte interaction at fertilization involves several combined interactions
between integrins on the oocyte and integrin ligands (disintegrins) on the sperm. Recent research has
indicated the ability of peptides containing the RGD sequence that characterized several sperm
disintegrins, to induce intracellular Ca2+ transients and to initiate parthenogenetic development in
amphibian and bovine oocytes. In the present study, we investigate the hypothesis that an integrin-
associated signalling may participate in oocyte activation signalling by determining the ability of a cyclic
RGD-containing peptide to stimulate the activation of protein kinase C (PKC) and the exocytosis of
cortical granules in mouse oocytes.
Methods: An In-Vitro-Fertilization assay (IVF) was carried in order to test the condition under which a
peptide containing the RGD sequence, cyclo(Arg-Gly-Asp-D-Phe-Val), was able to inhibit sperm fusion
with zona-free mouse oocytes at metaphase II stage. PKC activity was determined by means of an assay
based on the ability of cell lysates to phosphorylate MARKS peptide, a specific PKC substrate. Loss of
cortical granules was evaluated by measuring density in the oocyte cortex of cortical granules stained with
LCA-biotin/Texas red-streptavidin. In all the experiments, effects of a control peptide containing a non
RGD sequence, cyclo(Arg-Ala-Asp-D-Phe-Val), were evaluated.
Results: The IVF assay revealed that the fusion rate declined significantly when insemination was carried
out in the presence of cyclic RGD peptide at concentrations > or = 250 microM (P < 0.05, Student-
Newman-Keuls Method). When the peptide was applied to the oocytes at these concentrations, a dose-
dependent increase of PKC activity was observed, in association with a loss of cortical granules ranging
from 38+/-2.5 % to 52+/-5.4 %. Evaluation of meiotic status revealed that cyclic RGD peptide was
ineffective in inducing meiosis resumption under conditions used in the present study.
Conclusion: The presents results provide evidence that a cyclic RGD peptide highly effective in inhibiting
sperm-oocyte interaction stimulates in mouse oocytes the activation of PKC and the exocytosis of cortical
granules. These data support the view that RGD-binding receptors may function as signalling receptors
giving rise integrated signalling not sufficient for a full oocyte activation response. This study may
contribute to the understanding of possible negative effects of skipping gamete interaction in IVF
techniques.
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Background
At fertilisation the oocyte undergoes a series of rapid
changes responsible for the onset of the embryonic devel-
opment and the blockage of polyspermy. These changes,
collectively known as "oocyte activation", are under the
regulation of cytoplasmic signalling events activated in
the oocyte following a multi-step interaction with the fer-
tilising sperm [1-3]. It is well established that upon fusion
sperm releases into the oocyte a sperm-specific phosphol-
ipase C-zeta (PLCζ) which induces a rise in intracellular
Ca2+ capable of releasing metaphase arrest and driving the
zygote through the embryonic cell cycle [4]. Although the
Ca2+-mediated signal transduction pathway at fertiliza-
tion is not fully resolved, it seems to involve specific
kinases such as protein kinase C (PKC) known to be acti-
vated in many cell types through enzyme- or G-protein-
coupled receptors localised on plasma membrane [5,6].
However, due to the effectiveness of intracytoplasmic
sperm injection in most mammalian species [7], the
hypothesis that receptor-mediated pathways may partici-
pate in the oocyte activation process has been poorly
investigated.
It is well established that binding of sperm ligands to spe-
cific oolemma receptors is a prerequisite step in sperm-
oocyte interaction leading to fertilisation [8,9]. Candidate
molecules involved in gamete interactions include
integrins, transmembrane glycoproteins with het-
erodimeric structure (alpha-chain and beta-chain) that act
as co-receptors in many cell-cell interaction [10]. Individ-
ual integrins can bind to more than one ligand and about
half of them recognize the tripeptide sequence Arg-Gly-
Asp (RGD) present in the extracellular matrix proteins
such as fibronectin and vitronectin [11]. Integrins
expressed on the surface of mouse oocytes can be divided
into two groups: β 1 integrins (α2 β1, α3β1, α5 β1, α6 β1
and α9β1) and αv integrins (αv β1, αvβ3, αv β5; [12,13]).
Integrin recognition sequences known to play a role in fer-
tilization are the RGD sequence and other tripeptide
sequences such as TDE, QDE and FEE included in the
active site of fertilin beta, a component of the first mole-
cule identified as a sperm surface protein required for
sperm-oocyte fusion [14-18]. Recently it has been sug-
gested the hypothesis that sperm-oocyte binding and
fusion involve combined interactions between RGD-sen-
sitive integrins such as αv  β1 and RGD-insensitive
integrins such as α6 β1 integrins on the oocyte [19].
In order to clarify the role of integrins at fertilization, it is
important to consider that these molecules can serve not
only as structural receptors that participate in cell-cell and
cell-matrix interaction, but also as signalling receptors
that regulate intracellular pH [20], intracellular free Ca2+
[21], inositol lipid turnover [22] and protein phosphor-
ylation [23]. Recent research has indicated the ability of
peptides containing a RGD sequence to induce intracellu-
lar Ca2+ transients and to initiate parthenogenetic devel-
opment in amphibian and bovine oocytes [24-26],
indicating that RGD-binding receptors may function as
signalling receptors in oocytes as it occurs in other cell
types. Multiple intracellular signalling molecules are stim-
ulated following integrin-dependent adhesion. These
include members of mitogen-activated protein kinase
(MAPK) signalling pathways, Rho family GTPases, non-
receptor tyrosine kinases such as focal adhesion kinase
(FAK) and Src, and members of the lipid signalling path-
ways such as phosphatidyl-inositol 3-kinase (PI 3-K), and
protein kinase C [27-29]. PKC signalling is considered a
major regulator of oocyte activation acting both depend-
ently and independently from the fertilization calcium
signal [30,31]. Although its role is not clearly established,
it has been proposed that this kinase provides integrated
signals aimed to modulate the kinetics and the extent of
activation events such as Ca2+ spiking and cortical granule
exocytosis [32].
Based on the above observations, we put forward the
hypothesis that integrins may participate in the activa-
tion-associated signalling in mouse oocytes. To this end,
in the present study we investigated the ability of a cyclic
RGD peptide to activate a pathway leading to the stimula-
tion of protein kinase C and cortical granule exocytosis.
Methods
Reagents
All reagents were purchased from Sigma Chemical Com-
pany (St. Louis, MO) unless otherwise stated.
Peptides
The peptide containing the RGD sequence cyclo(Arg-Gly-
Asp-D-Phe-Val) [33] and the control peptide containing a
non RGD sequence cyclo(Arg-Ala-Asp-D-Phe-Val) [34],
were purchased from Peptide International, Inc. (Louis-
ville, Kentucky). As demonstrated by the manufacturer
when tested by thin layer chromatography both the pep-
tides showed a single spot. Lyophilised peptides were
resuspended in T6 medium [35] at 500 μM concentration
as indicated in the datasheet, aliquotted and stored at -
20°C and used within 3 weeks.
Oocyte and sperm isolation
Random bred Swiss CD1 female mice (22–25 days old,
Charles River, Como, Italy) were superovulated by intra-
peritoneal injection of 7.5 I.U. PMSG and 7.5 I.U. hCG 48
hr apart. After 14 hr mice were killed by cervical disloca-
tion. Oocytes were released from oviducts in M2 medium
[35] and the cumulus cells were dispersed by a brief expo-
sure to 0.3 mg/ml hyaluronidase. The zonae pellucidae
were removed by treatment (approximately 1 min) with
Tyrode's solution [36] and the zona-free oocytes were cul-Reproductive Biology and Endocrinology 2006, 4:48 http://www.rbej.com/content/4/1/48
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tured at 37°C, 5% CO2 in M16 medium for 1 hr before
their use in the experimental groups.
Spermatozoa were obtained by excising the caudae epidi-
dymides from two adult CD1 males (3–5 months old,
Charles River, Como, Italy) as previously described [31].
In vitro fertilisation and sperm fusion assay
The sperm suspension was diluted to obtain 50 μl insem-
ination drops containing 1–5 × 104 sperm/ml covered
with mineral oil. About 25 oocytes preincubated for 30
min in T6 containing peptides at different concentrations
or in T6 alone were incubated in each drop and main-
tained in the incubator at 37°C in 5% CO2 for 10–30 min.
Inseminated oocytes were freed from loosely associated
sperm before processing for the evaluation of the desig-
nated parameters. Further development of fertilised
oocytes was carried out in 50 μl drops of M16 medium.
To visualise sperm-oocyte fusion after fertilisation we
used the dye transfer technique as previously described
[37]. In this assay, upon fusion with oocytes preloaded
with the DNA-staining dye Hoechst 33342, sperm nuclei
become brightly fluorescent as the dye gains access and
binds sperm DNA. Oocytes were loaded with Hoechst
33342 (0.1 μg/ml) by a 15 min incubation, rinsed thor-
oughly in T6 medium and immediately incubated with
sperm. After 10 min of insemination, oocytes were col-
lected and washed in M2 before being fixed by a 15 min
incubation in 3.7% paraformaldehyde in PBS. Fixed
oocytes were mounted on slides and scored for the pres-
ence of fused sperm under a microscope fitted for epiflu-
orescence (Leitz Dialux, Leitz, Wien, Austria).
Protein kinase C assay
PKC activity was assayed using the protocol of Gallicano
et al. [30]. For each reaction, groups of 10 oocytes, col-
lected at different times of insemination, were washed in
collection buffer (phosphate buffered saline (PBS) con-
taining 1 mg/ml polyvinyl alcohol, 5 mM EDTA, 10 mM
Na3VO4, 10 mM NaF), transferred to a centrifuge tube in
2 μl of collection buffer and immediately submerged in
liquid N2 to flash-freeze the oocytes, followed by storage
at -80°C until the kinase assay was performed. The frozen
oocytes were thawed in 10 μl PKC buffer which contained
β-glycerophosphate (54 mM), para-nitrophenylphos-
phate (14.5 mM), MOPS (24 mM), MgCl2 (14.5 mM),
EGTA (14.5 mM), EDTA (0.12 mM), DTT (1 mM), leu-
peptin (1μg/ml), aprotinin (1 μg/ml), ML-9 (10 μM),
genestein (75 μM), chimostatin (1 μg/ml), tripsin-chimo-
tripsin inhibitor (1 μg/ml), PKI (2.4 μM), 50 μCi/ml ν-
[32P]ATP(Amersham Pharmacia Biotech, Italy) and
MARKS (2.5 mg/ml, BIOMOL, Plymouth Meeting, PA) as
a specific substrate. After 30 min at 37°C, assays were
stopped by adding tricine sample buffer (1:1) (Bio-Rad
Laboratories, Hercules, CA). Samples were electro-
phoresed and the gel was subjected to autoradiography as
previously described [38]. To inhibit PKC activity, BIM
was added to the assay buffer at a final concentration of 10
μM (control). Enzyme activity was semiquantified densit-
ometrically using a Bio-rad GS-670 computerised imaging
densitometer and Molecular Analyst software (Bio-rad
Laboratories, Hercules, CA). Intensity of bands were
quantified after background subtractions. For each autora-
diogram, 3 replicates were performed with 10 oocytes per
time-point per replicate and ratios of mean band density
in the experimental groups to that of BIM treated samples
(control) were evaluated. PKC activity at different time
points was expressed as mean ± SEM of ratios obtained
from at least 3 autoradiograms.
Staining and quantification of cortical granules
Oocytes were fixed in a 3.7% (w/v) paraformaldeyde and,
after permeabilization with Triton X-100, were incubated
with LCA (Lens Culinaris Agglutinin)-coupled to biotin
and then with Texas red-streptavidin as previously
described [38]. Briefly, the oocytes were mounted on slide
in 50% w/v glycerol and CGs in the cortex were visualised
by a fluorescence microscope equipped with a 100x objec-
tive and oil immersion. The CG density for each oocyte
was computed by image analysis based on the same prin-
ciples as manual counting described previously. The
images on flat optical fields of cortex resulting from par-
tial compression of the oocyte by the coverslip, were cap-
tured by a Vario Cam monochrome CCD and then
transferred to a PC with image analysis software (KS300,
Kontron Elektronik Gmbh, Germany) [38]. The density of
CGs per 100 μm2 for each oocyte was computed by image
analysis as the mean of the counts from tree equal areas of
cortex containing cortical granules. For each group, the
percentage loss of CGs from the cortex was calculated by
comparing the mean density of CGs of the treated group
with the mean density of CGs of the untreated control
group, according to the following equation: %CG loss = 1-
[density of CGs in treated group/density of CGs in
untreated group] × 100.
Evaluation of oocyte activation
Oocytes fixed in paraformaldehyde were stained with 3
mg/ml Hoechst 33342 for 10 min, mounted on slides and
monitored under an epifluorecence microscope for the
presence of chromosomes at anaphase and telophase or
pronuclei. As a positive control for oocyte activation,
oocytes were activated with 7% ethanol [37].
Statistical analysis
Each group of experiments was repeated at least three
times and data are presented as mean ± SEM, unless stated
otherwise. Multiple comparison of values were analysed
using Student-Newman-Keul's test (SigmaStat software;Reproductive Biology and Endocrinology 2006, 4:48 http://www.rbej.com/content/4/1/48
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Jandel Scientific Software Corporation, San Rafael, CA).
Proportions were compared using z-test. Differences asso-
ciated with a P value lower than 0.05 were considered sta-
tistically significant.
Results
Effect of a cyclic RGD containing peptide on sperm-oocyte 
interaction
As in the mouse RGD containing peptides are known to
interfere with sperm-oocyte interaction [16,17], we tested
the conditions under which a cyclic RGD peptide interacts
effectively with the oocyte by monitoring its ability to
inhibit fertilization. To this end we performed an IVF
assay where successful gamete interaction was assessed by
monitoring sperm fusion. As shown in Figure 1, the IVF
assay revealed that fusion rate declined significantly when
insemination was carried out in the presence of cyclic
RGD peptide at 250 μM (P < 0.05). A further increase to
500 μM was responsible for a further reduction of fusion
rate to about 20%, a value 3-fold lower than that observed
in the presence of the same concentration of the control
peptide. Since the control cyclic peptide failed to affect fer-
tilisation at any concentration tested (Figure 1), present
results were taken an indirect evidence of the peptide
interaction with integrin receptors on mouse oocytes.
PKC activity in mouse oocytes exposed to a cyclic RGD 
containing peptide
In further experiments we applied the peptide to the
oocytes at the concentration of 500 μM and then sub-
jected them to a PKC assay. Results from these assays
showed that the peptide exposure resulted in a significant
stimulation of the enzyme. This effect was seen as early as
5 min post-treatment, and after 60 min the PKC activity
reached a level about three-fold higher than that observed
in untreated oocytes (time 0; Figure 2A). As shown in Fig-
ure 2B, a significant increase in PKC activity could be
observed when RGD concentration was lowered to 250
μM although the level of activity was reduced as compared
with that observed at 500 μM. When oocytes were
exposed to the non RGD-peptide PKC activity did not sig-
nificantly increase as compared with that monitored in
untreated MII oocytes (Figure 2C). As shown in the same
figure, no change was seen when the treatment with the
cyclic RGD peptide was carried out in a Mg2+ and Ca2+-free
medium, a condition that prevent ligand-integrin interac-
tion [17,39].
Cortical granule exocytosis and meiotic status in mouse 
oocytes exposed to a cyclic RGD containing peptide
To establish whether the cyclic RGD peptide could induce
cortical granule exocytosis, mouse oocytes were incubated
in the presence of different concentrations of cyclic RGD-
and nonRGD peptides for 1 hr and processed for the eval-
uation of loss of cortical granules 2 hr later. As shown Fig-
ure 3, following the exposure to the cyclic RGD peptide,
the oocytes underwent CG exocytosis in a dose-dependent
manner. The loss of cortical granules ranged from 38 ± 2.5
% at 250 μM to 52 ± 5.4 % at 500 μM. Both these value
were significantly higher than that monitored in oocytes
exposed to the nonRGD peptide. As shown in the repre-
sentative micrographs in Figure 3b and 3d, evaluation of
meiotic status revealed that cyclic RGD peptide was inef-
fective in inducing meiosis resumption under conditions
used in the present study. To confirm this, in further
experiments we monitored the presence of oocytes at ana-
phase, telophase or pronuclei stage (activated oocytes)
following 8 hr from the exposure to 500 μM cyclic RGD-
or nonRGD peptides and to 7% ethanol, as a positive con-
trol. As shown in Table 1, the percentage of oocytes
treated with the cyclic RGD peptide and showing meiosis
resumption was statistically no different from than those
exposed to the nonRGD peptide or untreated.
Discussion
In this study, we provide evidence that exposure of mouse
oocytes to a cyclic RGD peptide can inhibit fertilization
and induce an activation-like response which includes the
activation of PKC signalling and exocytosis of cortical
granules. To our knowledge, this is the first report identi-
fying a potential role of integrins and their ligands in the
signalling events underlying mouse oocyte activation.
It is well known that in the mouse RGD-containing pep-
tides do not have a substantial inhibitory effect on sperm-
Effects of a cyclic RGD peptide on sperm-oocyte fusion Figure 1
Effects of a cyclic RGD peptide on sperm-oocyte 
fusion. ZP-free mouse oocyte were incubated in the pres-
ence of different concentrations of cyclic RGD or nonRGD 
peptides for 30 min prior to fertilization. Oocytes were then 
inseminated with 1–5 × 104 sperm/ml in the presence of pep-
tide. The results here represent the average of 3 experi-
ments per peptide concentration ± S.E.M. and a total of 60–
80 inseminated oocytes per experimental point. Means with 
different letters are statistically different (P < 0.05).Reproductive Biology and Endocrinology 2006, 4:48 http://www.rbej.com/content/4/1/48
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oocyte interaction as it occurs in other species, but cause a
partial inhibition of fertilization, an observation taken as
an evidence that sperm-oocyte fusion would utilize multi-
ple molecules and/or multiple sites on molecules [16,17].
Although in our IVF assay a complete inhibition of sperm
fusion was not achieved, the cyclic RGD peptide we
employed reveals a high biological activity being about
50% inhibition observed at 250 μM, a concentration ten-
fold lower than that required with linear RGD pep-
tides[17]. Nevertheless, we are not able to establish
whether higher concentrations of the peptide would have
been more effective since in this study the lyophilized
compound was dissolved at the maximal concentration
allowed according to manufacturer's instructions. How-
Cortical granule exocytosis in oocytes exposed to a cyclic  RGD peptide Figure 3
Cortical granule exocytosis in oocytes exposed to a 
cyclic RGD peptide. ZP-free mouse oocytes were incu-
bated in the presence of different concentrations of cyclic 
RGD or nonRGD peptides for 60 min and stained with LCA-
biotin/Texas red-streptavidin 2 hr later. A) Representative 
photomicrographs of cortical granules localized in the cortex 
and corresponding chromosomes of a MII oocyte (a, c) and 
an oocyte exposed to the RGD peptide (b, d). Final magnifi-
cation, ×1250. B) Histogram showing CG loss in oocytes 
exposed to cyclic RGD or nonRGD peptides. The results 
here represent the average of 3 experiments per peptide 
concentration ± S.E.M. and a total of 60–80 inseminated 
oocytes per experimental point. Bar = 10 μm. Means with 
different letters are statistically different (P < 0.05).
Effects of a cyclic RGD peptide on PKC activity Figure 2
Effects of a cyclic RGD peptide on PKC activity. PKC 
activity in ZP-free mouse oocytes incubated in the presence 
of cyclic RGD or nonRGD peptides. A, oocytes incubated in 
the presence of 500 μM RGD for 5 min or 60 min and proc-
essed for PKC assay. B, oocytes incubated in the presence of 
different concentrations of cyclic RGD peptide for 60 min. C, 
oocytes exposed for 60 min to 500 μM RGD peptide in the 
presence or in the absence of Ca2+ and Mg2+, and to 500 μM 
nonRGD peptide. PKC activity is expressed as mean ± SEM 
of ratios of density in the experimental group to that of BIM 
treated samples. Means with different letters are statistically 
different (P < 0.05).Reproductive Biology and Endocrinology 2006, 4:48 http://www.rbej.com/content/4/1/48
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ever, given that the RGD peptide inhibited sperm interac-
tion whereas the nonRGD did not, we have taken these
results as an indirect evidence of peptide binding to
integrin receptors.
In studies of integrin functions in gametes and somatic
cells, synthetic peptides containing the RGD (Arg-Gly-
Asp) motif have been extensively used as the inhibitors of
integrin-ligand interactions. Although the inhibitory
activity of disintegrins depends mainly from their primary
structure, structural and functional studies suggest that the
receptor binding ability of these proteins lies in subtle
positional requirements of the tripeptide RGD that is har-
boured in a defined hairpin loop (the disintegrin loop)
projecting from the disintegrin core. This has led to the
study of small, chemically synthesised, cyclic-RGD pep-
tides, which exert more potency than linear RGD in
integrin binding assay [40]. Thus it is likely that the cyclic
RGD peptide used in the present study mimics the physi-
ological action of RGD-containing proteins, supporting
the view that, along with proteins with other tripeptide
sequence such as fertilin [14], RGD-containing polypep-
tides located on sperm membrane, such as vitronectin
[41,42], play an important role in gamete interactions
leading to fertilization.
The analysis of PKC activity in oocytes exposed to the
cyclic RGD peptide at concentrations effective in inhibit-
ing sperm fusion revealed a significant increase in the
activity of this enzyme. This finding supports the hypoth-
esis that under this condition an oocyte-integrin signal-
ling cascade is activated to switch on an oocyte
phospholipase C leading to increased production of inosi-
tol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG)
[43]. DAG activates PKC and IP3 triggers Ca2+ release from
intracellular stores. The observation that oocytes exposed
to the RGD peptide undergo a significant loss of cortical
granules further suggests that under, our experimental
conditions, a RGD-sensitive receptor on the oolemma has
activated signalling pathways similar to those triggered by
sperm at fertilization. Moreover, the occurrence of cortical
granule exocytosis in association with an increased PKC
activity supports the role for this kinase in the regulation
of this event. On the other hand, being the loss of cortical
granules a Ca2+-dependent event [44], present results
might be an indirect evidence that oocytes exposed to the
RGD peptide had undergone an increase of intracellular
Ca2+ as suggested by a previous study [45]. There is still the
possibility that PKC activity in response to the RGD pep-
tide represents that observed at fertilization in the absence
of a Ca2+ signal and probably supported by Ca2+-inde-
pendent PKC isotypes [31]. In this respect, previous
results based on the use of PKC agonists and antagonists,
suggested that exocytosis can be triggered independently
either by Ca2+ rise and PKC [46,47]. Oocyte exposure to a
RGD peptide seems to be responsible for a reorganization
of actin network similar to that induced by sperm [48].
Moreover, as discussed by Tsaadon et al. [49], PKC may
regulate the cytoskeletal dynamic underlying exocytosis
enabling the process of vesicle fusion with plasma mem-
brane.
A further observation associated with present results is
that RGD-associated signalling leads to PKC activation
and cortical granule exocytosis but is not able to stimulate
meiosis resumption. This supports the hypothesis that, in
contrast to PKC activation achieved by pharmacological
agonists, the activation of a PKC signalling through a
receptor-mediated mechanism, is not the sufficient trigger
for the activation of the anaphase-promoting complex/
cyclosome (APC/C) pathway leading to meiosis resump-
tion [32,50]. In contrast to our results in the mouse, in
bovine oocytes a release of meiotic arrest is observed after
exposure to RGD peptides [25], it is likely that RGD-sen-
sitive receptors might be capable of activating additional
pathways.
Conclusion
Although further investigation will be needed, our results
suggest that, at fertilization, a sperm membrane protein
containing a RGD sequence may interact with a RGD-sen-
sitive receptor on the oolemma activating a cascade of sig-
nalling pathways involved in oocyte activation. Given that
in the mouse and bovine sperm injection can induce an
abnormal Ca2+  response with developmental conse-
quences [51,52], it can be speculated that a possible role
of integrin-mediated pathways may be that to cooperate
with those activated in the cytosol by other sperm mole-
cules [4] in order to correctly orchestrate oocyte activation
events. Although studies on animal models must be inter-
preted with caution, this hypothesis raises the need to bet-
ter investigate the consequences of skipping gamete
interaction at surface level in a number of assisted repro-
ductive technologies.
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